CLINICAL_TRIALS
trial_result
· 2022-03-11
Clinical Trial Update: Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy Patients [Phase 3]
Summary
Phase 3 trial comparing hypo-fractionation versus conventional fractionation in reconstructed breast cancer mastectomy patients; status not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Seoul National University Bundang Hospital | Conditions: Breast Cancer, Radiotherapy; Complications | Phase 3 | Status: NOT_YET_RECRUITING